Thursday, 07 November 2024 02:30 AM
Company Update
Germany held a dominant revenue in the Western Europe Peri-Implantitis Treatment Market and is expected to grow with a CAGR of 2.3%. China occupies a leading value share in East Asia market in 2023 and is expected to grow with a CAGR of 6.8% during the forecasted period.
NEWARK, DE / ACCESSWIRE / November 7, 2024 / The global market for peri-implantitis treatment is set to experience significant growth, with market value expected to rise from USD 2,689.1 million in 2024 to USD 5,191.9 million by 2034. Driven by a compound annual growth rate (CAGR) of 6.8% over the next decade, this increase reflects heightened demand and a growing awareness of peri-implantitis management among both patients and dental professionals.
Peri-implantitis, a local infectious condition that affects the soft and hard tissues surrounding dental implants, poses a serious threat to implant stability and patient satisfaction. This condition, characterized by inflammation that can lead to bone loss around the implant, jeopardizes the long-term effectiveness of dental implants, a popular solution for missing teeth due to both aesthetic and functional benefits. The rising adoption of dental implants globally has spurred the need for effective peri-implantitis treatments to ensure implant success and prevent complications.
A recent report from the National Center for Biotechnology Information (NCBI) highlights the prevalence of peri-implantitis in the United States, where a two-year cohort study found a 34% occurrence rate among patients and a 21% rate per implant. These findings underscore the urgency for enhanced awareness, preventive measures, and reliable treatments in the fight against this common but preventable implant complication.
Revenue from peri-implantitis treatment in 2023 was recorded at USD 2,517.9 million, highlighting the steady market expansion due to growing awareness and the critical need for effective treatment solutions. Industry stakeholders are expected to invest more in research and development, further advancing the peri-implantitis treatment landscape over the forecast period.
This anticipated growth reflects a pivotal trend in modern dentistry, where managing peri-implantitis has become essential to the long-term success of dental implants. As more people turn to implants as a durable and aesthetically pleasing option for tooth replacement, the global healthcare industry continues to prioritize innovations that will improve treatment effectiveness, ultimately contributing to better patient care and implant outcomes.
"With the demand for dental implants continually increasing, the need for efficient peri-implantitis management is more pressing than ever, The industry is responding with improved treatment options, from antibiotics to regenerative therapies, which will support implant longevity and patient outcomes." opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Advancements in Early Detection and Treatment Drive Growth in Peri-Implantitis Market:
The global peri-implantitis market is experiencing significant growth, driven by technological advancements in early detection and innovative treatment options. Peri-implantitis, an inflammatory condition affecting the soft and hard tissues surrounding dental implants, has become an increasing concern with the rising popularity of dental implants. The demand for effective and timely intervention is now at the forefront, pushing both healthcare providers and technology developers to focus on solutions that address prevention, diagnosis, and treatment.
Key Drivers and Trends Shaping the Market:
Innovation in Diagnostic Tools: Emerging technologies, such as imaging techniques and biomarker analysis, are enhancing the early detection of peri-implantitis. Advanced imaging solutions, including 3D dental scans, allow clinicians to detect subtle changes in tissue around implants, enabling prompt intervention and improved patient outcomes.
New Therapeutic Approaches: Alongside diagnostics, the development of minimally invasive treatments is gaining traction. Laser therapies and antimicrobial photodynamic therapy (aPDT) offer effective, low-impact options for addressing infection and inflammation. These options reduce recovery time and promote better patient compliance, making them favorable alternatives to more invasive methods.
Focus on Preventive Care: With increasing awareness among patients and healthcare providers, preventive strategies are becoming integral in peri-implant care. Regular screening, maintenance protocols, and educational programs on oral hygiene practices are essential in minimizing the risk of peri-implantitis and improving implant longevity.
Key Takeaways: Projected Economic Growth
India is poised for substantial growth with a projected 7.7% Compound Annual Growth Rate (CAGR).
China is expected to maintain a strong growth trajectory at 6.8% CAGR.
South Korea is projected to grow at a solid 5.4% CAGR.
United States is forecast to experience a more moderate growth rate of 2.1% CAGR.
Germany is projected to grow at a similar pace to the US, with a 2.3% CAGR.
Competitive Landscape:
To maintain a competitive edge, key players in the peripheral microcatheter market are implementing several strategic initiatives. These include:
Robust R&D Investment: Companies are significantly investing in research and development to improve material composition and design, aiming to enhance catheter performance and safety.
Strategic Partnerships and Acquisitions: Forming strategic alliances and acquiring smaller companies enables these players to expand their product portfolios and gain access to emerging technologies.
Recent Industry Developments:
Fotona Expands Training Capabilities: On July 6, 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. This center aims to enhance knowledge, foster collaboration, and promote clinical excellence in the field of laser dentistry.
Straumann Strengthens Peri-Implantitis Treatment Portfolio: On February 23, 2024, Straumann completed the acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge's innovative approach to peri-implantitis treatment, including its CE-marked device launched in 2020, will further bolster Straumann's offerings in this area.
Detailed Market Study: Full Report and Analysis
https://www.futuremarketinsights.com/reports/peri-implantitis-treatment-market
Key Players of Peri-implantitis Treatment Industry:
Pfizer Inc.
Cadila Pharmaceuticals
R N. Laboratories
Triveni Chemicals
Basic Pharma Life Sciences
Prachi Pharmaceuticals
Healthy Life Pharma Private Limited
Straumann AG
Fotona
Key Segments of Peri-implantitis Treatment Industry:
By Method Type:
In terms of method type, the industry is divided into surgical treatment of peri-implantitis (mechanical debridement, laser debridement, open flap debridement, open flap debridement with guided bone generation), non-surgical treatment of peri-implantitis (surface debridement, antibiotics (chlorhexidine digluconate), others.
By End User:
In terms of end user, the industry is segregated into peri-implantitis treatment in hospitals and peri-implantitis treatment in dental clinics
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Authored By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's related ongoing Coverage on Healthcare Market Insights Domain:
The global rare inflammatory disease treatment market size has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach a value of USD 17,335.8 Million.
The global antioxidants reagents market share are estimated to be worth USD 2,615.8 million in 2024 and anticipated to reach a value of USD 5,543.5 million by 2034. Sales are projected to rise at a CAGR of 7.8% over the forecast period between 2024 and 2034.
The global reagent filling systems market demand are estimated to be worth USD 10,253.6 million in 2024 and anticipated to reach a value of USD 18,190.1 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
The medical telepresence robots market growth is estimated to reach USD 70.5 million in 2024. It is estimated that revenue will increase at a CAGR of 4.4% between 2024 and 2034. The market is anticipated to reach USD 110.5 million by 2034.
The compression veterinary bandages market outlook by 2023, the compression veterinary bandages market is anticipated to be worth USD 117.0 million. During the forecast period of 2023 to 2033, the compression veterinary bandages business is predicted to record a CAGR of 3.2%, with a closing value of USD 161.1 million.
The radial compression devices sales The radial compression devices market size is projected to be valued at USD 255.5 Million in 2023 and is expected to rise to USD 599.9 Million by 2033. The sales of radial compression devices are expected to grow at a significant CAGR of 8.9% during the forecast period.
The global canine atopic dermatitis treatment market forecast expects a considerable valuation bump, from USD 1,182.60 million in 2024 to USD 1,620.50 million in 2034. The updated report points to a CAGR of 3.20% CAGR from 2024 to 2034.
The global atopic dermatitis treatment market overview is estimated to be worth USD 15,048.6 million in 2024 and anticipated to reach a value of USD 45,501.6 million by 2034. Sales are projected to rise at a CAGR of 11.7% over the forecast period between 2024 and 2034.
The global cartilage repair market trends is estimated to be worth USD 1,474.6 million in 2024 and anticipated to reach a value of USD 2,767.9 million by 2034. Sales are projected to rise at a CAGR of 6.5% over the forecast period between 2024 and 2034.
The global contrast media injectors market development is estimated to be worth USD 4,949 million in 2024 and anticipated to reach a value of USD 8,832.8 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
SOURCE: Future Market Insights Inc.